IL-4 (Plantigen)

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameIL-4 (Plantigen)
Drug Alias Nameimmune disorder therapy (IL-4) (Plantigen)interleukin-4 (Plantigen)
ClassificationNatural product/ExtractBiologics > Protein drugs > Recombinant polypeptide
Mechanisms of ActionInterleukin-4 receptors stimulants
TargetsInterleukin-4 receptors
Therapy Area/IndicationsImmune System Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanada
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesPlantigen Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesPlantigen Inc
Active IndicationsN/A
Inactive IndicationsImmune System Diseases

Other Information

ATC CodeN/A
Related LinksN/A